Ann Johnson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ann Johnson has a total of 1 co-authors. Here are the top co-authors by number of shared publications:
Jane Shekhdar
Physicist, (NHS Breast Screening Programme London and Eastern Regions), Department of Medical Physics Mount Vernon Hospital, Northwood, Middlesex, UK
2 shared publications
Latest Publications
- Open Access
- 28 July 2012
- Published by SAGE Publications in Journal of the Royal Society of Medicine
- Vol. 105 (7) , 317-319
‘Overdiagnosis’ and mortality in breast cancer screening
- 28 July 2012
- Published by SAGE Publications in Journal of the Royal Society of Medicine
- Vol. 105 (7) , 317-319
Open Access‘Overdiagnosis’ and mortality in breast cancer screening
- 13 January 2005
- Published by Wiley in Journal of Evaluation in Clinical Practice
- Vol. 11 (1) , 27-31
Breast cancer incidence: what do the figures mean?
Rationale, aims and objectives Against the background of a general rise in the incidence of breast cancer temporal variations appear in different age groups, including changes attributable to the introduction of breast screening. This paper attempts to distinguish the influence of breast screening and to examine any underlying patterns.Methods The incidence data published by the Office of National Statistics for England and Wales have been examined using the method of least squares regression. These data have been subjected to major revision: a new system was introduced in 1971. That year, therefore, has been taken as the starting point for the analyses. Regression lines were fitted from 1971, 1984 and 1988 (when breast screening was started).Results Between 1971 and 1984 breast cancer incidence was unchanged in women under 50 years. In all other age groups and time periods the incidence has risen throughout 1971–1999. The rate of increase remained constant for women over 64 but changed in 1984 for all women under 65 years. The rate of increase is rising exponentially with age since 1984 in the women under 65. The superimposed increases due to screening have been separated from the underlying rates.Conclusions In the period surveyed there appears to have been a change in the rates of increase in incidence of breast cancer in women under 65 that dates from 1984. This change can be separated from the spurious increase due to breast screening. The rates in women over 64 have remained constant.
- 13 January 2005
- Published by Wiley in Journal of Evaluation in Clinical Practice
- Vol. 11 (1) , 27-31
Breast cancer incidence: what do the figures mean?
Rationale, aims and objectives Against the background of a general rise in the incidence of breast cancer temporal variations appear in different age groups, including changes attributable to the introduction of breast screening. This paper attempts to distinguish the influence of breast screening and to examine any underlying patterns.Methods The incidence data published by the Office of National Statistics for England and Wales have been examined using the method of least squares regression. These data have been subjected to major revision: a new system was introduced in 1971. That year, therefore, has been taken as the starting point for the analyses. Regression lines were fitted from 1971, 1984 and 1988 (when breast screening was started).Results Between 1971 and 1984 breast cancer incidence was unchanged in women under 50 years. In all other age groups and time periods the incidence has risen throughout 1971–1999. The rate of increase remained constant for women over 64 but changed in 1984 for all women under 65 years. The rate of increase is rising exponentially with age since 1984 in the women under 65. The superimposed increases due to screening have been separated from the underlying rates.Conclusions In the period surveyed there appears to have been a change in the rates of increase in incidence of breast cancer in women under 65 that dates from 1984. This change can be separated from the spurious increase due to breast screening. The rates in women over 64 have remained constant.
- 1 August 2002
- Published by SAGE Publications in Journal of the Royal Society of Medicine
- Vol. 95 (8) , 427
Immunotherapy for cancer
- 1 August 2002
- Published by SAGE Publications in Journal of the Royal Society of Medicine
- Vol. 95 (8) , 427
Immunotherapy for cancer
- Open Access
- 1 August 2002
- Published by SAGE Publications in Journal of the Royal Society of Medicine
- Vol. 95 (8) , 427
Immunotherapy for Cancer
- 1 August 2002
- Published by SAGE Publications in Journal of the Royal Society of Medicine
- Vol. 95 (8) , 427
Open AccessImmunotherapy for Cancer
- 1 August 2001
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 68 (3) , 261-271
Does breast cancer grade worsen with time? Evidence from breast screening
It has been suggested that alteration of the distribution of histological grades, that has been found in screening programmes, is evidence for progression in histological grade with increasing size....
- 1 August 2001
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 68 (3) , 261-271
Does breast cancer grade worsen with time? Evidence from breast screening
It has been suggested that alteration of the distribution of histological grades, that has been found in screening programmes, is evidence for progression in histological grade with increasing size....
- 1 April 2000
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 60 (3) , 201-209
The timing of treatment in breast cancer: gaps and delays in treatment can be harmful
‘Timing’ of treatment in breast cancer may refer to intervals within a single management or between different managements. Rates of shrinkage of breast cancers in response to treatment are related to...
- 1 April 2000
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 60 (3) , 201-209
The timing of treatment in breast cancer: gaps and delays in treatment can be harmful
‘Timing’ of treatment in breast cancer may refer to intervals within a single management or between different managements. Rates of shrinkage of breast cancers in response to treatment are related to...